Skip to main content

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Community Health Systems, Inc. (CYH)

The law firm of Kirby McInerney LLP is investigating potential claims against Community Health Systems, Inc. (“Community Health” or the “Company”) (NASDAQ:CYH). The investigation concerns whether Community Health and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

[Click here to learn more about the investigation]

On February 21, 2024, Community Health disclosed that it was under investigation by the Department of Justice in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the SEC. The Company revealed that it had received a Civil Investigative Demand on January 11, 2024 for “documents and information relating to a variety of subjects, including practices and procedures related to utilization review, inpatient admissions and inpatient dialysis at [the Company’s] hospitals.” On this news, the price of Community Health shares declined by $1.14 per share, or approximately 28.2%, from $4.04 per share on February 20, 2024 to close at $2.90 per share on February 21, 2024.

If you purchased or otherwise acquired Community Health securities, have information, or would like to learn more about this investigation, contact Thomas W. Elrod of Kirby McInerney LLP by email at, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.